We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Spectral Karyotyping Detects Chromosome Damage Linked to Smoking and Lung Cancer

By HospiMedica staff writers
Posted on 11 Sep 2007
Spectral karyotyping (SKY) detects chromosome damage in bronchial cells of smokers and patients with lung cancer.

Lung cancer is the leading cause of cancer deaths in the United States and kills more people than the next three most common cancers--colon, breast, and prostate--combined. More...
Smoking is the primary risk factor for lung cancer but a number of lung cancer patients have never smoked. Quitting smoking only gradually reduces the risk of lung cancer because much of the genetic damage done by tobacco is irreversible.

The genetic changes that accompany lung cancer are not random, but are associated with specific chromosomal instabilities that may be indicative of future carcinomas. Marileila Varella-Garcia, M.D., and colleagues of the University of Colorado Health Sciences Center (UCHSC; Denver, CO, USA) used SKY to examine the bronchial epithelium (BE) of 71 subjects--14 patients with lung cancer, 43 smokers at high risk for developing lung cancer, and 14 healthy nonsmokers--in the hope of identifying underlying genetic changes that might be hallmarks for cancer. They found a marked difference between the chromosomal abnormality index (CAI) of never-smokers and that of high-risk smokers and patients with lung cancer.

"There's a tremendous amount of chromosomal damage in smokers who don't yet have cancer,” said Dr. Wilbur Franklin, professor of pathology at the University of Colorado Health Sciences Center. "Chromosomal abnormalities were observed in 82% of high-risk smokers and in all patients with carcinoma, regardless of their self-reported tobacco exposure.” Patients with cancer and high-risk smokers had nearly 23 and 15 times more chromosomal abnormalities, respectively, than never-smokers.

The study, which could pave the way toward screening people at risk for lung cancer for genetic changes that foreshadow malignancies, appeared in the September 1, 2007, issue of the American Journal of Respiratory and Critical Care Medicine.


Related Links:
University of Colorado Health Sciences Center

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.